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A B S T R A C T   
Background: Smartphone-based applications to identify cardiac implantable electronic devices (CIED) are 
extremely useful in circumstances, where urgent device interrogation is needed, and a device identification card 
is not available. Few studies have provided insights regarding the utility of these applications. We have studied 
two widely available applications i.e., Pacemaker ID app (PMIDa) or Cardiac Rhythm Management Device-Finder 
(CRMD-f) to identify device manufacturers in CIEDs. 
Methods: 547 patients who underwent CIED implantation from the year 2016–2020 in our institute were 
enrolled. There were 438 Medtronic and 109 St. Jude’s devices. All chest radiographs were de-identified and 
resized into 225*225 pixels focusing on the CIED. PMIDa and CRMD-f applications were used to identify the 
CIED. Accuracy, sensitivity, specificity, negative predictive value, and positive predictive value for both appli-
cations were calculated and compared. 
Results: Overall, CRMD-f application has higher specificity (93.58 vs. 82.5%) but lower sensitivity (53.6 vs. 55%) 
than PMIDa. The accuracy of both applications was comparable (61.6% vs. 60.5%). Accuracy varied with CIED 
model and type tested, and radiograph projection used. Accuracy is greatest with Cardiac-Resynchronization- 
Therapy (CRT) devices for both applications, followed by a single lead pacemaker. 
Conclusion: CRMD-f has higher accuracy and specificity for CIED manufacturer identification. Both PMIDa and 
CRMD-f are specific tools to identify CIED but have low sensitivity.   
1. Introduction 
Cardiac implantable electronic devices (CIED) are increasingly being 
implanted across the world. With an expansion in the number of CIED 
implanted every year, physicians frequently encounter the need of de-
vice interrogation [1]. Timely interrogation of CIED helps with quicker 
diagnosis and management of patients with cardiovascular disease. 
Furthermore, patients with CIED need device interrogation and changes 
in the device parameters to safely perform emergency surgery. Emer-
gency Department (ED) staff can now interrogate CIED with similar 
interrogation time and have no impact on the length of ED stay and 
similar 30-days outcomes when compared to the standard procedures of 
interrogation in ED [2,3]. However, significant time is spent in 
retrieving information about the device manufacturer from the medical 
records in circumstances when the device identification card is not 
available, which can potentially delay the necessary therapies for 
certain arrhythmias or delay the emergency treatment required. 
Smartphone-based applications like Pacemaker ID application 
(PMIDa) and Cardiac Rhythm Management Device-Finder (CRMD-f) 
have been designed to aid with quicker recognition of device manu-
facturers so that manufacturer-specific equipment is arranged for the 
device interrogation. Either of the two applications needs validation 
studies to ascertain their usefulness in device manufacturer 
identification. 
PMIDa is a smartphone-based application that uses neural network- 
driven model to recognize the device manufacturer (Fig. 1) [4]. It is also 
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available as a website. CRMD-f is a mobile-based application that was 
developed by Dr. Ines Sherifi and Tarun Kotia and includes a 
flow-chart-based inspection of CIED using the CaRDIA-X algorithm 
(Fig. 2). CaRDIA-X is Cardiac Rhythm Device Identification Algorithm 
using X-rays. This algorithm utilizes the fact that every device has 
certain unique radiographic and morphologic features such as the shape 
of the battery, CAN, and header position concerning the battery, pres-
ence of coils, etc., which can facilitate device identification [5] (Fig. 3). 
2. Methods 
This was a single-center, observational study approved by the Aga 
Khan University Hospital Ethics Review Committee (ERC Number: 
2020-5101-14156). The patient enrollment period ranged from 2015 to 
2020. All subjects who underwent CIED implantation during this study 
period and undergoing chest radiograph after the procedure at any time 
were enrolled in the study. Chest radiographs were obtained from the 
electronic medical record system of the hospital. Commonly used 
manufacturers in the institute included Medtronic and St. Jude Medical. 
Physicians using the applications were blinded to the manufacturer 
and were pre-trained to use the applications on a set of 20 radiographs. 
A single Nokia phone (13-megapixel camera) was used for all the de-
vices. Screen resolution was 1366*768. Both anterior-posterior (AP) and 
posterior-anterior projections (PA) were used. 
547 CIED implanted from the year 2015–2020 were enrolled. 
Manufacturer representation includes Medtronic 80.1% (438) and St. 
Jude Medical 19.9% (109) of patients. The unequal distribution of the 
device manufacturer was due to local availability and hospital contract 
with the device manufacturer. All chest radiographs were de-identified. 
Each X-ray was cropped and resized into 225*225 pixels. For every 
CIED, manufacturer identification was attempted using PMIDa and 
CRMD-f. The physician using both methods was blinded of the original 
manufacturer. Sensitivity and specificity for both methods were 
compared. 
Analysis was performed using SPSS version 23. Descriptive analysis 
was used to calculate respective frequencies. Cross-tabulation was used 
for calculating individual accuracies, sensitivities, specificities, negative 
predictive values (NPV), and positive predictive values (PPV). Accu-
racies were separately calculated for individual model and device type. 
For a PMIDa to detect manufacturer, a cut-off of 75% was used as a 
prediction certainty. The answer was considered correct for the appli-
cations if the answer matched the real manufacturer (known from 
medical records). 
The work has been reported in line with the STROCSS criteria [6]. 
The project has been registered with clinicaltrial.gov (UIN: 
NCT04957108) [7]. https://clinicaltrials.gov/ct2/show/NC 
T04957108. 
3. Results 
A total of 547 CIED were analyzed. There were 368 dual-chamber 
pacemakers, 122 single implantable cardioverter defibrillators (ICD), 7 
single lead permanent pacemakers, and 15 Cardiac Resynchronization 
Therapy (CRT) devices. Device models interrogated are as shown in 
Table 1. Chest radiograph projection was anteroposterior in 87 (14.6%) 
and posteroanterior in 460 devices (76.8%). 
PMIDa sensitivity in identifying device manufacturers was 55% and 
specificity was 82.5%. PMIDa negative predictive value (NPV) was 31% 
and the positive predictive value (PPV) was 92.6%. CaRDIA-X algorithm 
carried a sensitivity of 53.6% and specificity of 93.58% with an NPV of 
33.4% and PPV of 97% (Table 2 and Fig. 4). 
When compared to PMIDa, the accuracy of CRMD-f was lower for 
Medtronic (56.6% vs. 57.9%) and higher for St. Jude Medical (94.4% vs. 
75.2%). CRMD-f had 100% accuracy for single-lead PPM and CRTs. 
PMIDa also correctly identified 100% of CRTs. PMIDa had higher ac-
curacy with AP-projection when compared to PA-projection (72.4% vs. 
59.3%), whereas CRMD-f had higher accuracy with PA-projection (98.5 
vs. 94%). (Table 3). 
4. Discussion 
Cardiology staff on-call often gets called for urgent interrogation of 
CIED. This entails consults from ED or peri-operative areas. Often, our 
patients fail to show CIED identity cards in emergency situations. In such 
circumstances, where urgent interrogation and programming of CIED 
are needed and the manufacturer name and device type are not known, 
either a PMIDa or CRMD-f with CaRDIA-X algorithm can be used to 
identify the device manufacturer. 
In this study, we have used CRMD-f mobile application instead of 
manual CaRDIA-X flow-chart and compared it with PMIDa. Our study 
points towards variability concerning the manufacturer, device type, 
and X-ray projections used. Overall, CRMD-f had higher specificity 
(93.58 vs. 82.5%) but relatively lower sensitivity (53.6 vs. 55%) than 
PMIDa. We compared our sub-group accuracies to the one demonstrated 
in Chudow et al. study and found the interpretations mentioned in 
Table no. 3. In essence, when compared to the manual CaRDIA-X 
flowchart used in Chudow et al. the CRMD-f application had greater 
accuracy for St. Jude’s Medical and single lead ICDs whereas a lesser 
accuracy for Medtronic CIED. Based on the device type, both the studies 
reported lesser accuracy with PPM in comparison to ICDs. 
Chudow et al. looked at the head-to-head comparison of the accuracy 
Fig. 1. Pacemaker ID application user interface.  
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of various machine learning algorithms in identifying CIED. The study 
used a manual CaRDIA-X flow-chart whereas our study used a mobile 
phone application-based CaRDIA-X algorithm. Chudow et al. reported 
an average accuracy of 88% for ICDs and 80% for PPMs with a vari-
ability of 71–99% depending upon the manufacturer being tested. 
Likewise, PMIDa had an overall accuracy of more than 75% (range: 
51%–100%). The manual CaRDIA-X flow-chart was reported to be time- 
consuming and cumbersome when compared to PMIDa [8]. This 
brought us to the testing of CRMD-f which is an application-based 
CaRDIA-X flow-chart and allows quicker user interface and identifica-
tion of the device. In comparison to Chudow et al. study, we demon-
strated lesser sensitivity and specificity, pointing towards inter-study 
variability. 
The respective accuracies of our study and Chudow et al. for Med-
tronic devices were: 57.9 vs. 96% (PMIDa) and 56.6 vs. 72% (CRMD-f vs. 
manual CaRDIA-X flow chart). For pacemakers overall, the accuracies 
were 52.5 vs. 83% (PMIDa) and 50.6 vs. 88% (CRMD-f vs. manual 
CaRDIA-X flow chart). Both the studies individually demonstrated 
relatively higher accuracy for ICD vs. PPM when using PMIDa (This 
Fig. 2. Cardiac Rhythm Management Device Finder application user interface.  
Fig. 3. Radiographic parts of the cardiac implantable electronic device.  
Table 1 
Device models tested in the study.  
Device Model Number (n) Percentage (%) 
Medtronic PPM Sensia 89 14.9 
Medtronic Evera S MRI ICD 30 5 
Medtronic Bravaquard CRT-D 17 2.8 
Medtronic Attesta PPM MRI 4 0.7 
Medtronic Ensura DR MRI PPM 265 44.2 
Abbot Fortify Assura 27 4.5 
Others 115 21%  
Table 2 
Sensitivity, specificity, and accuracy of Pacemaker ID app and CRMD-finder app.  
Application Sensitivity (%) Specificity (%) Accuracy (%) 
PacemakerID 55 82.5 60.5 
CRMD-Finder 53.6 93.58 61.6  
Fig. 4. Sensitivity, specificity, and accuracy of Pacemaker ID app and CRMD- 
finder app. 
P. Shams et al.                                                                                                                                                                                                                                  
Annals of Medicine and Surgery 69 (2021) 102741
4
study: 52.5 vs. 75.4% for PMIDa; Chudow et al.: 83% vs. 95%). The 
inter-study variability for PMIDa can be explained by the difference in 
mobile phone manufacturer and camera megapixel used in both the 
studies (iPhone 8 12 megapixels versus Nokia 13 megapixels), the dif-
ference in screen resolutions used, and the difference in projections 
used. Additionally, differences in the extent of data augmentation (such 
as flipping and cropping of radiograph images) can lead to variability. 
The variability for CRMD-f or CaRDIA-X algorithm can be due to inter- 
physician variability i.e., level of professional training. This aspect de-
termines one’s familiarity with device identifiers on visual inspection of 
the chest radiograph. 
Additionally, our study concluded that for a machine-learning-based 
application (PMIDa) AP projection yields greater accuracy (72.4% vs. 
59.3%) whereas, for a flow-chart-based application, the PA projection 
yields higher accuracy (98.5% vs. 94%). This is likely because PMIDa 
involves taking picture of the device and an AP projection theoretically 
magnifies anterior structures (including CIED). 
The use of the CaRDIA-X algorithm is shown to have intra-operator 
variability with the electrophysiologists showing best performance, 
owing to their greater familiarity with devices and algorithms. An 
accuracy-variability amongst physicians of 62.3%–88.9% has been re-
ported [9]. In our study, CRMD-f was used by two cardiology 
fellows-in-training (FIT) of the same professional year who were 
pre-trained to grow familiarity with the radiographic anatomy of de-
vices. Our study was limited by the fact that physicians interpreting the 
radiographs were not of different professional levels. Our study is clin-
ically applicable and in more correlation with the ground reality, 
wherein emergency situations mostly cardiology FIT need to interrogate 
the CIED. 
The use of neural-network-based artificial intelligence (AI) for 
identifying CIED is gaining attention. A single centered study compared 
the network with that of cardiologists and found that neural network- 
based AI performs better than the cardiologists to identify CIED 
(99.6% vs. 72%) [9]. However, other studies [8,10] including ours show 
variable accuracies pointing towards the variable performance of neural 
networks. The difference in the accuracy of various neural network 
methods can be explained by the difference in training sets and software 
used for machine learning. 
Despite the variable results, artificial intelligence maintains its 
attraction due to its ease of use and quicker results. Importantly, like 
with any technology, it might restrict cardiologists’ ability to manually 
identify devices based on certain morphologic characteristics. CaRDIA-X 
is superior to PMIDa in terms of output because it not only identifies the 
device manufacturer but also the CIED type. The impact of these device 
identification tools on patient outcomes in terms of time-to-diagnosis 
and time-to-therapy has yet to be studied. We are planning to analyze 
the difference in prognostic outcomes concerning different modalities 
and applications used for device identification as our future project. We 
will assess if efficient and timely device information results in better 
management decisions for patients with CIED. 
4.1. Study limitations 
Our study was a single-centered study, and we were limited by the 
lack of availability of CIED manufacturers other than Medtronic and St. 
Jude Medical. Prospective data on patient outcomes is lacking and needs 
further research. 
5. Conclusion 
CRMD-f has higher accuracy and specificity for CIED manufacturer 
identification. Both PMIDa and CRMD-f are specific tools to identify but 
have lesser sensitivity. Accuracy is greatest with CRTs for both appli-
cations, followed by single lead PPM. Both methods demonstrate vari-
ability across the studies. Our study is one of the few studies testing AI 
for CIED identification using chest radiograph and the first one from a 
low-middle income country. 
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